Cardiovascular disease remains a leading global cause of death, and we break down its pathology, risk factors, and the ...

Contemporary cardiology faces a paradox: unprecedented technological capability coincides with declining scientific curiosity ...

Please provide your email address to receive an email when new articles are posted on . HeartFlow announced it has received FDA 510(k) clearance on two new noninvasive artificial intelligence-powered ...

In a multicenter, randomized, double-blind, placebo-controlled, noninferiority trial, we enrolled 5246 men 45 to 80 years of age who had preexisting or a high risk of cardiovascular disease and who ...